Treatment of diseases using endothelin antagonists
US6380241B1 · kind B1 · utility
7Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2000 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | Nov 17, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/59
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.